Search results
...Plaintiff Deadline Approaching in Class Action Against Checkpoint Therapeutics, Inc. – Contact...
Benzinga· 4 days agoCKPT securities between March 10, 2021 and December 15, 2023. For more information...Company's third-party contract manufacturing organization ("CMO") for cosibelimab; (iii) all the foregoing ...
BrainStorm Cell Therapeutics to Present New Biomarker Data Suggesting ALS Patients May Benefit From...
FOX 59 Indianapolis· 6 days agoBrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, will present new biomarker ...
Immunity Boosting Combination Therapy for Myelodysplastic Syndrome (pre-Leukemia) Treatment: A...
NewMediaWire via Yahoo Finance· 1 day agoUS FDA-IND 131300 (ABV-1702)FREMONT, CA - (NewMediaWire) - May 24, 2024 - ABVC BioPharma, Inc....
Terran Biosciences prepares for trials of schizophrenia drug
Clinical Trials Arena via Yahoo Finance· 1 day agoKarXT was originally developed by Karuna Therapeutics until BMS acquired the company in a $14bn...
Cartesian (RNAC) Up as FDA Grants RMAT Tag to Descartes-08
Zacks· 3 days agoFree Report) announced that the FDA has granted the Regenerative Medicine Advanced Therapy (RMAT) designation to its lead pipeline candidate, Descartes-08, for the treatment ...
Earnings call: BiomX reports Q1 2024 results, optimistic on phage therapies By Investing.com
Investing.com· 4 days agoThe company's lead candidates, BX004 and BX211, are making significant progress in Phase II trials,...
Esperion's (ESPR) Drugs Get EU Nod for Lowering Heart Risk
Zacks via Yahoo Finance· 2 days agoThe drugs are already approved for treating elevated LDL-C and CV risk reduction in the United...
CANTEX PHARMACEUTICALS RECEIVES FDA ORPHAN DRUG DESIGNATION FOR AZELIRAGON FOR THE TREATMENT OF...
WKRN Nashville· 5 days agoFood and Drug Administration (FDA) has granted Orphan Drug Designation to Cantex' azeliragon, a well-tolerated once-a-day pill, for the treatment of pancreatic cancer. This ...
Virios Therapeutics Announces Pricing of $1.7 Million Public Offering of Common Stock to Commence...
Benzinga· 6 days agoVirios Therapeutics, Inc. VIRI (the "Company" or "Virios Therapeutics"), a development-stage biotechnology company focused on advancing novel antiviral ...
Neurotoxin referred to as ‘vegan Botox’ used to minimize fine lines, wrinkles in adults as young as...
Fox News via Yahoo News· 1 day agoMedical spa personnel are testing and using Daxxify, the latest FDA-approved injectable neurotoxin...